文献速递神经肿瘤

成人毛细胞型星形细胞瘤患者的临床特征与预后因素

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.
PubMed 文献 · J Neurooncol · 2020-04-27

该研究基于维也纳医科大学神经生物样本库2000至2018年间46例成人毛细胞型星形细胞瘤患者,分析其临床病程与预后因素。中位随访53.0个月,9/46(19.6%)出现进展或复发,5年总生存率和无进展生存率分别为85.3%和70.0%。年龄>40岁和较高体重指数与无进展生存和总生存受损相关(p<0.05)。

要点

  • 成人毛细胞型星形细胞瘤中位诊断年龄32.5岁,中位Ki67增殖指数2.8%。
  • 9/46(19.6%)患者在中位随访53.0个月后出现肿瘤进展或复发。
  • 年龄>40岁和较高体重指数与无进展生存和总生存受损相关(p<0.05)。

核心结论

  • 成人毛细胞型星形细胞瘤的复发或进展率高于儿童患者报告的水平。
  • 较高年龄和较高体重指数与预后不良相关。

研究设计与样本

  • 从维也纳医科大学神经生物样本库识别2000年至2018年间诊断时为18岁及以上、接受神经外科切除或活检的毛细胞型星形细胞瘤患者46例。
  • 对2例复发时组织病理学诊断不同的病例,使用Illumina Infinium HumanMethylation850 BeadChip(850k)阵列和分子神经病理分类器进行DNA甲基化分析。
  • 将临床病理特征与患者结局进行相关性分析。

主要发现

  • 诊断时中位年龄为32.5岁(范围:19-75岁),中位Ki67增殖指数为2.8%(0.5-13.4%)。
  • 肿瘤位置与可切除性显著相关(p < 0.001)。
  • 中位随访53.0个月(范围0.5-300个月)后,9/46(19.6%)患者出现肿瘤进展或复发。
  • 5年总生存率和无进展生存率分别为85.3%和70.0%。
  • 2/9(22.2%)例复发肿瘤标本出现组织学变化,甲基化分类将组织学诊断分别重新定义为伴毛样特征的间变性星形细胞瘤和胶质瘤各一例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Pilocytic astrocytoma (PA) is the most common primary brain neoplasm in children and treated in curative intent with gross total resection (GTR). However, PA is rare in adults, resulting in limited knowledge on the natural clinical course. This study aimed to describe the clinical course and identify prognostic factors of adult patients with PA. METHODS: 46 patients ≥ 18 years at diagnosis of PA and neurosurgical resection or biopsy between 2000 and 2018 were identified from the Neuro-Biobank of the Medical University of Vienna. In two cases with differing histopathological diagnosis at recurrence, DNA methylation analysis was performed using Illumina Infinium HumanMethylation850 BeadChip (850 k) arrays and the Molecular Neuropathology classifier. Clinico-pathological features were correlated with patient outcomes. RESULTS: Median age at diagnosis was 32.5 years (range: 19-75) and median Ki67 proliferation index was 2.8% (0.5-13.4%). Tumor location significantly correlated with resectability (p < 0.001). Tumor progression or recurrence was observed in 9/46 (19.6%) patients after a median follow up time of 53.0 months (range 0.5-300). 5-year overall and progression-free survival rates were 85.3% and 70.0%, respectively. 2/9 (22.2%) patients presented with histological changes in the recurrent tumor specimen. In detail, methylation classification redefined the histological diagnosis to anaplastic astrocytoma with piloid features and glioma in one patient, each. Age > 40 and higher body mass index (BMI) were associated with impaired progression-free and overall survival (p < 0.05). CONCLUSIONS: Tumor recurrence or progression in adult PA patients was higher than the one reported in pediatric patients. Higher age and BMI were associated with impaired prognosis.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Mair MJ, Wöhrer A, Furtner J, et al. Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma. J Neurooncol. 2020. PMID: 32342331. doi:10.1007/s11060-020-03513-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。